Faculty

Institution

Unit

Venue

Jahangir Abdi

California State University--Dominguez Hills

Affiliations

California State University--Dominguez Hills

NoneJahangir Abdi is currently serving as a California State University--Dominguez Hills faculty at California State University--Dominguez Hills.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jahangir Abdi

California State University--Dominguez Hills

You can click a keyword to filter the displayed items

hematology oncology hematological malignancies molecular biology pharmacology pathology tumor biology cancer discovery cancer cells oncogenes medicinal research multiple myeloma urology epigenetics drug resistance cancer research tumor microenvironment haematopoiesis surgical oncology vascular biology molecular cancer bone marrow transplantation leukemia educational strategies professional development distance education educational assessment disease progression microrna detection tumor heterogeneity cancer genetics myeloid neoplasia tumor suppressors rna biology cancer genomics thrombopoiesis health profession training remote teaching outcome-based education epigenetics-microrna axis multiple myeloma pathogenesis micro-rna interplay coagulation system secondary hemostasis transcriptome modulation bortezomib resistance multiple myeloma cells clinical laboratory education

Notable Scholarly Works

Notable Federal Grants

Collaborators

Evaluating the Impact of Remote Teaching on Competency‑Based Outcomes in Clinical Laboratory Education. American Journal of Clinical Pathology (2026)

program evaluationclinical laboratory educationmedical educationeducational strategieseducational assessmentremote teachingeducationdistance educationhealth profession trainingeducational technologyoutcome-based educationprofessional developmenteducational research

Abnormalities of Primary and Secondary Hemostasis in Multiple Myeloma: Insights From Studies on Thrombopoiesis, the Coagulation System, and the Bone Marrow Microenvironment. Frontiers in Hematology (2025)

coagulation systemhematologymultiple myelomahematological malignancieshaematopoiesisthrombopoiesisleukemiabone marrow transplantationsecondary hemostasisimmunologypathology

Priming of Bone Marrow Stromal Cells With the Epigenetic Modifier Decitabine Overcomes Stroma-Mediated Resistance to Bortezomib in Multiple Myeloma Cells.. Blood (2025)

Toll-Like Receptor 1/2 Activation Reduces Immunoglobulin Free Light Chain Production by Multiple Myeloma Cells in the Context of Bone Marrow Stromal Cells and Fibronectin. PLoS ONE (2025)

Ectopic Expression of Birc5-Targeting Mir-101-3P Overcomes Bone Marrow Stroma-Mediated Drug Resistance in Multiple Myeloma Cells. BMC Cancer (2019)

Dysregulation of Ezh2/Mir-138 Axis Contributes to Drug Resistance in Multiple Myeloma by Downregulating Rbpms. Leukemia (2018)

Targeting Cd47 and Tnfaip8 by Mir-155 Overcomes Drug Resistance and Inhibits Tumor Growth Through Induction of Phagocytosis and Apoptosis in Multiple Myeloma. Blood (2018)

Inhibition of the Epigenetic Modifier Ezh2 by Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma. Blood (2017)

Role of Epigenetics-Microrna Axis in Drug Resistance of Multiple Myeloma. Journal of Hematology & Oncology (2017)

Nasrin RastgooJahangir AbdiJian HouHong Chang

drug resistancepharmacologyurologytumor biologyoncologyepigenetics-microrna axiscancer discoverydisease progressionmultiple myelomamedicinal researchtumor heterogeneityhematologyepigeneticssurgical oncologyhematological malignanciescancer cellsoncogenesmicrorna detectionmolecular biologycancer genetics

Role of Tumor Suppressor P53 and Micro-Rna Interplay in Multiple Myeloma Pathogenesis. Journal of Hematology & Oncology (2017)

Jahangir AbdiNasrin RastgooLihong LiWenming ChenHong Chang

tumor suppressorsrna biologytumor biologymultiple myeloma pathogenesisoncologycancer researchcancer discoverytumor microenvironmentcancer genomicsmolecular cancerimmunologyvascular biologyhematologyhematological malignanciescancer cellsoncogenesmicro-rna interplaymolecular biologypathologymyeloid neoplasia

1
2
3
10 / page

Jahangir Abdi

California State University--Dominguez Hills

Affiliations

California State University--Dominguez Hills

NoneJahangir Abdi is currently serving as a California State University--Dominguez Hills faculty at California State University--Dominguez Hills.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jahangir Abdi

California State University--Dominguez Hills

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Evaluating the Impact of Remote Teaching on Competency‑Based Outcomes in Clinical Laboratory Education. American Journal of Clinical Pathology (2026)

coagulation systemhematologymultiple myelomahematological malignancieshaematopoiesisthrombopoiesisleukemiabone marrow transplantationsecondary hemostasisimmunologypathology

Priming of Bone Marrow Stromal Cells With the Epigenetic Modifier Decitabine Overcomes Stroma-Mediated Resistance to Bortezomib in Multiple Myeloma Cells.. Blood (2025)

Toll-Like Receptor 1/2 Activation Reduces Immunoglobulin Free Light Chain Production by Multiple Myeloma Cells in the Context of Bone Marrow Stromal Cells and Fibronectin. PLoS ONE (2025)

Ectopic Expression of Birc5-Targeting Mir-101-3P Overcomes Bone Marrow Stroma-Mediated Drug Resistance in Multiple Myeloma Cells. BMC Cancer (2019)

Dysregulation of Ezh2/Mir-138 Axis Contributes to Drug Resistance in Multiple Myeloma by Downregulating Rbpms. Leukemia (2018)

Targeting Cd47 and Tnfaip8 by Mir-155 Overcomes Drug Resistance and Inhibits Tumor Growth Through Induction of Phagocytosis and Apoptosis in Multiple Myeloma. Blood (2018)

Inhibition of the Epigenetic Modifier Ezh2 by Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma. Blood (2017)

Role of Epigenetics-Microrna Axis in Drug Resistance of Multiple Myeloma. Journal of Hematology & Oncology (2017)

Nasrin RastgooJahangir AbdiJian HouHong Chang

Role of Tumor Suppressor P53 and Micro-Rna Interplay in Multiple Myeloma Pathogenesis. Journal of Hematology & Oncology (2017)

Jahangir AbdiNasrin RastgooLihong LiWenming ChenHong Chang

1
2
3
10 / page